Cognex Co. (NASDAQ:CGNX - Free Report) - Equities research analysts at DA Davidson issued their Q2 2025 earnings estimates for shares of Cognex in a research note issued on Monday, May 5th. DA Davidson analyst M. Summerville forecasts that the scientific and technical instruments company will post earnings per share of $0.17 for the quarter. DA Davidson has a "Neutral" rating and a $32.00 price objective on the stock. The consensus estimate for Cognex's current full-year earnings is $0.61 per share. DA Davidson also issued estimates for Cognex's FY2026 earnings at $0.81 EPS.
Cognex (NASDAQ:CGNX - Get Free Report) last announced its earnings results on Wednesday, February 12th. The scientific and technical instruments company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Cognex had a net margin of 11.61% and a return on equity of 5.65%.
A number of other equities research analysts have also recently commented on the company. Hsbc Global Res cut Cognex from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 21st. Truist Financial reduced their price target on shares of Cognex from $37.00 to $29.00 and set a "hold" rating for the company in a research report on Tuesday, April 8th. Cowen raised Cognex from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Stephens reaffirmed an "overweight" rating and issued a $55.00 target price on shares of Cognex in a report on Wednesday, March 12th. Finally, The Goldman Sachs Group reduced their price objective on shares of Cognex from $33.00 to $29.00 and set a "sell" rating on the stock in a research report on Tuesday, May 6th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $39.17.
Check Out Our Latest Stock Report on CGNX
Cognex Stock Up 0.2 %
Shares of NASDAQ:CGNX traded up $0.05 during midday trading on Tuesday, reaching $29.47. The company's stock had a trading volume of 2,988,050 shares, compared to its average volume of 1,546,503. Cognex has a 12-month low of $22.67 and a 12-month high of $53.13. The firm has a 50 day moving average of $28.13 and a 200-day moving average of $34.56. The firm has a market capitalization of $4.95 billion, a P/E ratio of 48.31 and a beta of 1.45.
Institutional Investors Weigh In On Cognex
Several hedge funds have recently bought and sold shares of the stock. Gagnon Securities LLC lifted its holdings in Cognex by 33.9% during the first quarter. Gagnon Securities LLC now owns 9,891 shares of the scientific and technical instruments company's stock valued at $295,000 after purchasing an additional 2,504 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Cognex by 5.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,507,022 shares of the scientific and technical instruments company's stock valued at $44,954,000 after buying an additional 79,266 shares during the period. ING Groep NV acquired a new position in shares of Cognex in the 1st quarter valued at $22,191,000. Blair William & Co. IL increased its position in shares of Cognex by 11.0% during the first quarter. Blair William & Co. IL now owns 21,180 shares of the scientific and technical instruments company's stock valued at $632,000 after acquiring an additional 2,107 shares during the last quarter. Finally, Manchester Capital Management LLC increased its stake in Cognex by 41.0% during the first quarter. Manchester Capital Management LLC now owns 2,750 shares of the scientific and technical instruments company's stock worth $82,000 after purchasing an additional 800 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.
Insider Transactions at Cognex
In related news, EVP Carl Gerst sold 6,803 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $32.73, for a total value of $222,662.19. Following the transaction, the executive vice president now owns 4,566 shares in the company, valued at approximately $149,445.18. This represents a 59.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.60% of the company's stock.
Cognex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, May 15th will be issued a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend is Thursday, May 15th. Cognex's payout ratio is 47.06%.
About Cognex
(
Get Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Recommended Stories
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.